(Q70124459)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2007943%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

title

Muscle carnitine deficiency in patients using valproic acid (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2007943%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

author name string

Y Shapira

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2007943%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

A Gutman

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2007943%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

language of work or name

English

0 references

publication date

1 April 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2007943%20AND%20SRC:MED&resulttype=core&format=json

The Journal of Pediatrics

8 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2007943%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

volume

118

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2007943%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

issue

4 Pt 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2007943%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

page(s)

646-649

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2007943%20AND%20SRC:MED&resulttype=core&format=json

Carnitine deficiency and hyperammonemia associated with valproic acid therapy

8 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983396-7

Serum carnitine during valproic acid therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983396-7

Plasma carnitine deficiency. Clinical observations in 51 pediatric patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983396-7

Decreased serum carnitine in valproate induced Reye syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983396-7

Systemic carnitine deficiency simulating recurrent Reye syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983396-7

Mitochondria-lipid-glycogen myopathy, hyperlactacidemia, and carnitine deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983396-7

Muscle carnitine levels in neuromuscular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983396-7

Carnitine metabolism in valproate-treated rats: the effect of L-carnitine supplementation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983396-7

Carnitine Deficiency of Human Skeletal Muscle with Associated Lipid Storage Myopathy: A New Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983396-7

Valproic acid hepatic fatalities: a retrospective review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983396-7

10.1016/S0022-3476(05)83396-7

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2007943%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

1 reference